Data, data, data
DATE: 2 March 2023 (16:00-18:00 GMT)
When your business idea is all about innovating around data and especially human data there are many considerations. This session debates:
- Ethics: How can you create value from data?
- Data belongs to individuals – why does that matter?
- What are the legal issues of creating, curating, storing, and accessing data?
- Finding the data you need – build your own vs partnering.
- Determine and articulate your approach to the data within your idea.
- Business models, customer or user acquisition and pricing in the context of data businesses.
Sarion Bowers, Head of Policy, Wellcome Sanger Institute
Sarion Bowers is the Head of Policy at the Wellcome Sanger Institute. She completed her PhD in Biochemistry at the University of Cambridge before continuing her research in DNA packaging and gene regulation in the UK and the US. She changed careers and now specialises in science and technology policy relating to genomics. Sarion has a particular interest UK science policy, data protection and the ethical, legal and societal issues that arise from the use of genomics, including genome editing.
Santiago Miriuka, Co-founder and CEO, MultiplAI Health
Co-Founder and CEO of MultiplAI Health, a startup developing a liquid biopsy for vascular disease. Cardiologist, with 20+ years in heart failure and heart transplantation. He holds an MD degree (UNLP, Argentina), an MSc in Cell Biology (UofT, Canada), an MSc in Clinical Trials (LSHTM, UK), and a PhD (UNLP, Argentina). He founded the Stem Cells Lab at FLENI, a tier-1 health institution in Argentina, working on cutting-edge cellular and molecular biology.
James Peach, CEO, Human Centric
James is the CEO of Human Centric, an Oxford University spinout improving neurology drug discovery by bringing more human data to the process, backed by Oxford Science Enterprises. He has been at cutting edge of developing and commercialising genetics and healthcare data in the UK, since setting up Cancer Research UK’s Stratified Medicine Programme with AstraZeneca and Pfizer, and the parallel Stratified Medicine Innovation Platform with the Technology Strategy Board (now Innovate UK).